Nequine Tablet

About Nequine 250 mg Tablet

Nequine 250 mg Tablet is a chloroquine phosphate medicine used in the treatment and prevention of malaria and in some other conditions. It belongs to the anti-malarial group of drugs and is taken only under a doctor's guidance.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Nequine 250 mg Tablet?

Nequine 250 mg Tablet is made by G. A. Company Ltd. and contains chloroquine phosphate, a medicine from the anti-malarial drug class. It is used for treating malaria attacks and for preventing and suppressing malaria. It is also used in amoebic hepatitis and amoebic abscess, in discoid and systemic lupus erythematosus, and in rheumatoid arthritis. Chloroquine works against the malaria parasite in the blood and is also effective in amoebiasis outside the intestine. In rheumatoid arthritis it has a disease-modifying effect. Because the medicine can affect the eyes and other organs when used for long periods, it should be taken only as your doctor advises, and the doctor decides the dose and course.

Uses of Nequine

Nequine 250 mg Tablet is used for the treatment of malaria and for the prevention and suppression of malaria. It is also used in the treatment of amoebic hepatitis and amoebic abscess, in discoid and systemic lupus erythematosus, and in rheumatoid arthritis. Your doctor will decide whether this medicine suits your condition and how long it should be taken.

How to use Nequine

Take Nequine 250 mg Tablet exactly as your doctor tells you. The doctor decides the dose, the number of doses and the length of the course, and this can differ between people and between conditions. Swallow the tablet with water. Do not change the dose or stop the course on your own. If you miss a dose, ask your doctor or pharmacist what to do. Store the medicine at room temperature in a dry place, away from light.

Side effects of Nequine

Nequine 250 mg Tablet is usually well tolerated at standard doses. Headache and stomach or bowel upset may occur and are not serious in most people. With prolonged high-dose use, side effects can be more severe: skin eruptions, occasional loss of skin colour or hair loss, difficulty in focusing, and blurred vision. Corneal changes clear when the drug is stopped. Rarely, low platelets, low white cells and aplastic anaemia have been reported. Long-term high-dose therapy can rarely cause irreversible retinal damage. Tell your doctor about any side effect.

Safety and precautions

Chloroquine should be used with caution in people with porphyria who also have liver dysfunction or cirrhosis, as it may worsen symptoms, especially in alcoholics. People who take it continuously at higher doses for more than twelve months, or weekly for more than three years as malaria prevention, need eye examinations at three-month intervals. Use during pregnancy should be avoided if possible unless the doctor judges the benefit outweighs the risk. Tell your doctor about all other medicines you take, as some interact with chloroquine. Ask your doctor first if you have liver problems, eye problems or are pregnant or breastfeeding.

Frequently asked questions

What side effects should I watch for, and when should I call the doctor?

Watch for headache, stomach upset, skin rash, hair loss, blurring of vision or difficulty in focusing. Call your doctor if any of these appear or worsen, or if you notice unusual bleeding or bruising. Long-term use needs eye checks as your doctor advises.

What is Nequine 250 mg Tablet used for, and what kind of medicine is it?

It is an anti-malarial medicine containing chloroquine phosphate. It is used to treat malaria and to prevent and suppress it, and also in amoebic hepatitis and abscess, lupus erythematosus and rheumatoid arthritis. Your doctor will confirm whether it is right for you.

Who should avoid it or ask the doctor first?

Ask your doctor first if you have porphyria with liver dysfunction or cirrhosis, liver or eye problems, or if you are pregnant or breastfeeding. Tell the doctor about all other medicines you take, because some medicines interact with chloroquine. Never start or stop it on your own.

Can I decide the dose and course myself?

No. The doctor decides the dose, the number of doses and how long you take Nequine 250 mg Tablet, and this varies between people and conditions. Follow the doctor's instructions exactly and do not change or stop the course without advice.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.